Novartis AG
COMBINATION OF A MCL-1 INHIBITOR AND A TAXANE COMPOUND, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
Last updated:
Abstract:
A combination comprising a MCL-1 inhibitor and a taxane compound, and compositions and uses thereof.
Status:
Application
Type:
Utility
Filling date:
5 Jan 2018
Issue date:
7 Nov 2019